Show document

A+ | A- | | SLO | ENG

Title: Učinkovitost in varnost alpeliziba pri zdravljenju HR+, HER2-, PIK3CA-mutiranega razsejanega raka dojk : raziskava iz realnega sveta Authors: ID Godina, Eva (Author) ID Ribnikar, Domen (Author) ID Borštnar, Simona (Author) Files: PDF - Presentation file, download (60,60 KB) MD5: F080E0F7990F518659F5446D5F192CA9   Language: Slovenian Typology: 1.13 - Published Professional Conference Contribution Abstract Organization: OI - Institute of Oncology Keywords: onkologija, rak dojke, kemoterapija Publication status: Published Publication version: Version of Record Year of publishing: 2022 Number of pages: Str. 147-148 PID: 20.500.12556/DiRROS-16228  UDC: 618.1 COBISS.SI-ID: 141115907  Publication date in DiRROS: 09.02.2023 Views: 678 Downloads: 185 Metadata:    Cite this work Plain text BibTeX EndNote XML EndNote/Refer RIS ABNT ACM Ref AMA APA Chicago 17th Author-Date Harvard IEEE ISO 690 MLA Vancouver : Copy citation

Share: Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a monograph

Title:	34. onkološki vikend : ob 25-letnici Združenja za senologijo SZD
Editors:	Srdjan Novaković
Place of publishing:	Ljubljana
Publisher:	Kancerološko združenje Slovenskega zdravniškega društva, Onkološki inštitut
Year of publishing:	2022
ISBN:	978-961-7029-51-2
COBISS.SI-ID:	129701123

Back